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Speciﬁc cytokines have been tested clinically for immunotherapy of cancers; however, cytotoxicity has often impaired their
usefulness. Consequently, alternative approaches are increasingly desirable. Dioscorea spp. tuber is a widely used traditional
Chinese medicinal herb claimed to confer immunostimulatory activity. In this study, we evaluated Dioscorea as an adjuvant
therapy for use alongside chemotherapy for cancer. Phytocompounds from Dioscorea tubers were ethanol fractioned and used
for ex vivo splenocyte proliferation assay or in vivo force-feeding of mice pre-treated with the chemotherapy agent 5-ﬂuorouracil.
Co-treatment with a 50–75% ethanol-partitioned fraction of the tuber extract of D. batatas (DsCE-II) and interleukin (IL)-
2 resulted in a signiﬁcantly higher rate of murine splenocyte cell proliferation ex vivo than treatment with DsCE-II or IL-2
alone. This DsCE-II fraction, which contains a polysaccharide with a high proportion of β-1,4-linkage mannose (≥64%), also
promoted the regeneration of speciﬁc progenitor cell populations in damaged bone marrow tissues of 5-ﬂuorouracil-treated mice.
Colony-forming unit (CFU) analyses demonstrated that the population of CFU-GM cells, but not CFU-GEMM or BFU-E cells,
preferentially recovered to ∼67% in the bone marrow of immune-suppressed mice fed with DsCE-II. DsCE-II eﬃcacy level was
∼85% ofthat obtained by subcutaneous administrationof recombinantG-CSF proteins (5μgkg −1) in mice tested in parallel.This
study suggests that the DsCE-II fraction of D. batatas extract may be considered for further development as a dietary supplement
for use alongside chemotherapy during cancer treatment.
1.Introduction
Over the last decade, there has been rapid growth in the
use of alternative medicines. Natural products, including
many plants traditionally used as medicinal herbs, are
being re-evaluated as key components in future medicine
or nutritional science [1]. Many researchers believe that
medicinal botanicals may be useful in regenerative and pre-
ventive medicine, especially for tissue-healing and immune-
enhancing activities. Recently, however, there has been
concern about the safety and eﬀectiveness of these remedies
[1–8]. Therefore, systematic rigorous scientiﬁc studies of
frequently used medicinal or nutritional supplement herbs
are urgently needed.2 Evidence-Based Complementary and Alternative Medicine
In Asia, Dioscorea spp. is a popularly used, traditional
Chinese medicinal (TCM) herb that is generally taken alone
or in multiple-herb formulations for a range of ailments.
Some biological eﬀects of Dioscorea spp., including the
induction of hypoglycemia in experimental mice and rabbits
[9, 10], as well as anti-bacterial [11], antioxidative and
hypolipidemic activities [12], have been reported. Anecdotal
evidence suggests that Dioscorea tubers taken as a food
supplement may promote human health by “regulating and
upgrading the immune responses” [13]; however, credible
experimental data is still lacking.
A fundamental aspect of the immune system is the
induction and regulation of the proliferation of speciﬁc
immune cell populations. The spleen is the major site of
immune responses to blood-borne antigens and is also a
site of hematopoiesis in rodents [14]. Bone marrow tissues
consist of pluripotent hematopoietic stem cells as well as
stromal cellswhich providedelicateenvironments for growth
and development of stem cells [15].
In this study, we used murine splenocytes and bone
marrow cell proliferation systems ex vivo and in vivo to eval-
uate the bioactivity of a partially puriﬁed phytocompound
fraction of Dioscorea tuber extract on murine immune cell
systems. This study aimed to accumulate scientiﬁc evidence
to evaluate more than 1000 years of use of this traditional
herbal medicine as an immune-modulator.
2.Methods
2.1. Preparation of Dioscorea Plant Crude Extracts. We used
three species [D. batatas Decne., D. alata L. and D. pseudo-
japonica)a n do n ec u l t i v a r ,D. alata (D. alata L. var. purpurea
(Roxb.) M. Pouch.] of the genus Dioscorea. The authenticity
of all plant material was validated by Dr Sin-Yie Liu, Taiwan
Agricultural Research Institute. Cultivation, growth, taxon-
omy, and agricultural practice details have been previously
reported [16].Dioscoreatuberswerepeeled,sliced(2–4mm),
lyophilized, and stored in a desiccator at room temperature
until use. Dried slices of plant tubers slices were ground in a
mortar prior to aqueous extraction. The extraction protocol
is shown in Figure 1 In brief, 10g tuber powder was mixed
with 100mL Milli-Q water, stirred for 1h at room temper-
ature and centrifuged at 24000g for 20min at 4◦C. The
supernatant was ﬁltered through glass wool. The pellet was
resuspended with another 100mL water, stirred, centrifuged
andre-extractedasabove.Thesupernatantsfromtwoextrac-
tions were then pooled to yield a crude extract (CE)fraction,
with 16.6% dry weight of the original raw materials. The
CE fraction was further extracted stepwise with 50, 75 and
87.5% (V/V) ethanol. The ethanol-insoluble fractions were
collected by centrifugation at 24000g for 20min at 4◦C; the
pelletwaslyophilizedandthendissolvedin sterilized waterat
10mgmL−1.Thefractions werenamedDsCE-I,DsCE-IIand
DsCE-III.The yieldofDsCE-I,-IIand -IIIwas4.34,2.24and
1.82% dry weight, respectively, of the CE. Limulus amoebo-
cyte lysate (LAL) assays (Associates of Cape Cod, Falmouth,
MA, USA) were performed to detect possible endotoxin
contamination. The level of endotoxin found in DsCE-II was
lower than 0.04EUμg−1 in each tested preparation.
Freshly-peeled tuber slices
Lyophilization
Dried tuber slices (21.4% of wet wt.)
Aqueous extraction and centrifugation
Precipitate
Precipitate
Precipitate
Precipitate
Lyophilization
Lyophilization
Lyophilization
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Supernatant
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Supernatant
Crude extract (CE)
(16.64% of dry wt.)
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Figure 1:Protocolforpreparation andbio-organicfractionationof
Dioscorea plant extracts. wt., weight.
2.2. Fractionation and Characterization of DsCE-II from
D. batatas. Anion ion exchange column chromatography
was used for DsCE-II fractionation. Forty-milligram DsCE-
II in 5mM Na2HPO4 (pH 7.5) buﬀer was loaded onto a
Q Sepharose Fast Flow ion exchange column (Pharmacia,
Stockholm, Sweden) pre-equilibrated with the same buﬀer.
Fractionated DsCE-II was collected from the eluants with a
0–0.75 M NaCl gradient in 5mM Na2HPO4 buﬀer (pH 7.5).
The protein and saccharide contents in each fraction were
determined with a spectrophotometer by absorbance at A280
and the phenol-sulfuric acid method [17], respectively.
2.3. Mice. Female BALB/c mice aged 8–12 weeks from the
National Laboratory Animal Breeding and Research Center,
Taipei, Taiwan, were maintained under standard pathogen-
free conditions. All facilities were approved by the Academia
Sinica Institutional Animal Care and Utilization Committee
(IACUC),and all animal experiments were conducted under
the institutional guidelines established by the Animal Core
Facility and IACUC in Academia Sinica, Taipei, Taiwan.Evidence-Based Complementary and Alternative Medicine 3
2.4. Preparation of Splenocytes and Bone Marrow Cells.
Murine splenocytes were prepared as previously described
[18] with minor modiﬁcations. Mouse spleens were surgi-
cally removed and minced at room temperature in RPMI
1640 medium. The tissue debris was removed by passing
the cell suspension through a cotton column, and ery-
throcytes were then lyzed by the addition of ACK buﬀer
(150mM NH4Cl, 1.0mM KHCO3,0 . 1m MN a 2EDTA, pH
7.2). The splenocytes were grown in RPMI 1640 medium
supplemented with 10mM HEPES (pH 7.0), non-essential
a m i n oa c i d s ,5 0μM β-mercaptoethanol, 0.03% l-glutamine,
50μgmL −1 gentamycin and 10% heat-inactivated (56◦C,
30min) fetal bovine serum. Bone marrow cell isolation fol-
lowed the methods described by Randall [19] and Wlodarski
et al. [20].
2.5. Cell Proliferation Determination using the H-thymidine
Incorporation Assay. Splenocytes (2 × 105 per well) were
seeded in a 96-well plate, with a ﬁnal volume of 200μL.
Herbal extracts or chemicals were added at the indicated
concentrations, incubated for 48h, and then labeled for
1 6hwi th1μCi/well 3H-thymidine (NET027X,speciﬁc activ-
ity 20Cimmol−1, NEN Life Science, Boston, MA, USA).
Concanavalin A (Con A) (1μgmL −1)a n dw a t e r( s o l v e n t
for Dioscorea extract) were applied as positive and negative
controls, respectively. Triplicate culture samples were treated
at indicated dosage. The labeled cells were harvested with
a Cell Harvestor (Packard, Meriden, CT, USA) following
the manufacturer’s instructions, and radioactivity was deter-
minedbyTopCount·NXT(Packard,Meriden,CT,USA). 3H-
thymidine incorporation is expressed as the radioactivity in
counts per minute per well of the experimental group minus
the counts per minute from the negative control (medium
only) set.
2.6. Treatment of Mice with 5-FU and Herb Extracts. 5-FU
was used to depress murine hematopoietic cells as described
by Wlodarski et al. [20]a n dC a oe ta l .[ 21]. Female BALB/c
mice were divided into groups of three animals each. A
single dose of 5-FU (100mgkg−1 body weight) or water
only (negative control) was injected intraperitoneally into
test mice. Starting 24h after 5-FU administration, mice
were force-fed cucumber extracts (10 or 50mgkg−1 body
weight) or Dioscorea extracts (10mgkg−1 body weight), or
given subcutaneous injections of rmG-CSF (5μgkg −1 body
weight) for 5 consecutive days, once every day. Animals
were sacriﬁced 24h after administration of the ﬁnal dose of
Dioscorea or G-CSF.
2.7. Colony-Forming Unit Assay. The colony-forming activi-
ties of CFU-GEMM, BFU-E and CFU-GM in bone marrow
cells (BMCs) were evaluated by culturing mouse femur
and tibia BMCs in methylcellulose medium (Methocult
GF M3434, Stem Cell Technologies, Vancouver, CA, USA).
Murine BMCs were diluted to a ﬁnal cell density of 1 ×
105/mL in Iscove’s Modiﬁed Dulbecco’s Medium containing
2% fetal bovine serum. For duplicate cultures, 0.3mL of cell
suspension was added to 3mL of M3434 medium, gently
vortexed and allowed to stand for 5–10min to dissipate air
bubbles. Aliquots of 1.1mL cell suspension were dispensed
into 35-mm culture dishes using an 18-G needle-attached
syringe. The culture dishes were rotated gently to spread
the methylcellulose gel evenly onto the substratum. Cell
cultures were incubated for 12 days at 37◦Cw i t h5 %C O 2
in a humidiﬁed (≥95%) incubator, and the cell colonies and
colony types were evaluated and counted under an inverted
microscope (IX70; Olympus).
2.8. Sugar Composition and Linkage Analysis. Sugar com-
position was determined by gas chromatography mass
spectroscopy (GC-MS). GC–MS was carried out using a HP-
5MS fused silica capillary column (30m × 0.25mm i.d.,
H e w l e t tP a c k a r d )a t6 0 ◦C on a gas chromatograph (HP6890,
Hewlett Packard) connected to an mass selective detector
(HP5973, Hewlett Packard). The heat proﬁles for analyses
of TMS and FAMEs were 60◦C for 1min, increasing to
140◦Ca t2 5 ◦Cmin −1 and 200◦Ca t5 ◦Cmin −1,a n dﬁ n a l l yt o
300◦Ca t1 0 ◦Cmin −1. For partially methylated aditol acetate
derivatives, the oven heat proﬁle was 60◦Cf o r1m i nb e f o r e
increasing to 290◦Ca t8 ◦Cmin −1, and ﬁnally to 300◦Ca t
ar a t eo f1 0 ◦Cmin −1. Peaks were analyzed by GC-MS and
compared with an established database. Arabitol derivative
was used as an internal standard.
The GC-MS analysis of Dioscorea tuber extract was
performed by methanolysis with 0.5 M methanolic/HCl at
80◦C for 16 h, and trimethylsilyation with the Sylon HTP
(HMDS/TMCS/pyridine, 3:1:9) trimethylsilyation reagent
(Supelco).Theﬁnaltrimethylsilyated (TMS)derivativeswere
kept in n-hexane for GC-MS analysis [1]. Hakomori methy-
lation analysis wasused toexamine carbohydrate linkage [2].
The test polysaccharide was pre-O-methylated with methyl
iodide and dimethylsulfoxide anion in dimethylsulfoxide,
a n dt h e nh y d r o l y z e db y2Mt r i ﬂ u o r o a c e t i ca c i da t1 2 0 ◦Cf o r
2h. The solvent was evaporated by a stream of compressed
air, and the residue was reduced with 0.45M NaBD4 in 1
MN H 4OH for 2h at room temperature. The reaction was
quenched with 100% acetic acid and co-evaporated with
10% acetic acid/methanol. The residue was peracetylated
with acetic anhydride at 100◦C for 1h. After CHCl3/H2O
partition, the sample was suspended in n-hexane, and ﬁnally
analyzed by GC-MS. The analytical methods for GC-MS
followed the parameters as reported previously [22, 23].
2.9. Statistical Analysis. All data are expressed as means ±
SD. Diﬀerences between treatments were determined using
SPSS statistics 17.0 with Student’s t-test (two-tailed) or
ANOVA. P<. 05 was considered statistically signiﬁcant.
Levels of conﬁdence are indicated as: ∗P<. 05; ∗∗P<. 01
and ∗∗∗P<. 001.
3.Results
3.1. DsCE-II Stimulates Growth of Murine Splenocytes in
Primary Culture. In the absence of pre-treatment with
known mitogens (e.g., phytohemagglutinin, concanavalin A
or cytokines), the DsCE-II fraction of D. batatas increased
the proliferation of murine splenocytes in a dose-dependent
manner (P<. 001) (Figure 2(a)). This suggests that4 Evidence-Based Complementary and Alternative Medicine
speciﬁc phytocompounds in DsCE-II could confer spe-
ciﬁc immunomodulatory activities resulting in splenocyte
proliferation. In contrast, DsCE-I failed to induce cell
proliferation,andDsCE-IIIonlyinducedslightproliferation.
In the linear range (100–500μgmL −1) of DsCE-II stimula-
tion, unless otherwise indicated, we chose 250μgmL −1 for
subsequent experiments.
The crude water extract and the derived DsCE-I, -II
and -III subfractions of D. batatas were further studied for
their possible cytotoxicity on cell proliferation, using human
skinﬁbroblast (CCD966SK),human hepatoma (Hep G2 and
Huh 7) and human mammary carcinoma (MCF-7) cell lines
in standard MTT assays [24]. The Dioscorea extracts and
subfractions exhibited no detectable cytotoxic activity, that
is, between 96 and 105% cell viability was observed for test
cell samples as compared with control samples (data not
shown).
3.2. Eﬀect of DsCE-II and IL-2 Co-Treatment on Splenocyte
Proliferation. We incubated splenocytes with mixtures of
increasing amounts of DsCE-II extract from D. batatas and
a ﬁxed concentration (2ngmL−1) of interleukin (IL)-2. Even
atlowconcentrations(50μgmL −1),DsCE-IIeﬀectivelystim-
ulated the splenocyte growth induced by IL-2 (Figure 2(b)).
The addition of 250μgmL −1 DsCE-II and 2 ngmL−1 IL-2
together resulted in a 3.2-fold higher cell proliferation
activity than the sum of stimulatory levels of DsCE-II and
IL-2 individually (square symbol in Figure 2(b)). Thus, IL-
2 and DsCE-II acted in concert to synergistically enhance
splenocyte proliferation. A similar synergistic proliferation
was also observed when a ﬁxed concentration (250μgmL −1)
of DsCE-II was combined with various doses of IL-2 up to
5ngmL −1, in cell proliferation assays (data not shown). In
parallel, plant extract samples from an Orchidaceae herb,
Anoectochilusformosanus,weresimilarly testedfortheireﬀect
on splenocyte proliferation. No synergy was detected (data
not shown). Taken together, our results demonstrate that IL-
2 and DsCE-II can synergistically enhance the proliferation
of mouse splenocytes ex vivo.
3.3. Co-Stimulatory Activities in Four Varieties of Dioscorea
Plants. To detect whether the cell proliferative and syn-
ergistic eﬀect above was speciﬁc to D. batatas,D s C E - I I
extracts from four species/cultivars of Dioscorea were tested
for their eﬀects on splenocyte proliferation and their ability
to enhance IL-2-mediated cell growth. DsCE-II fraction
from D. batatas had a more signiﬁcant eﬀect on splenocyte
proliferation than the DsCE-II fractions from the other
species/cultivars; this observation was also true with respect
to the synergistic eﬀects of IL-2 (P<. 001) (Figure 2(c)).
These results suggest that the stimulatory eﬀect on spleno-
cyteproliferationexhibited by DsCE-II plant species/cultivar
is speciﬁc and demonstrate the importance of using speciﬁc
plant species and standardized preparation(s) of herbal
extracts for therapies.
3.4. DsCE-II Promotes Regeneration of Murine BMCs and
Splenocytes in 5-FU-Treated Mice. To assess the possible
immunomodulatory eﬀect of Dioscorea extracts in vivo,w e
force-fed Dioscorea extracts to BALB/c mice. Oral feeding
was chosen because in many Asian cultures, Dioscorea is
consumedasaconstituentoftonicteasorsoups.Theeﬀectof
DsCE-II on spleen or BMC numbers of healthy normal mice
was negligible. We therefore assessed the eﬀects of Dioscorea
on immune-impaired mice. Mice were ﬁrst treated for 1
day with the chemotherapeutic drug 5-FU. 5-FU is strongly
cytotoxic to mitotic active tumor cells but also has profound
side eﬀects, including toxic eﬀects on the lymphoid, myeloid
and otherhematopoietic cellsin bone marrow tissue [19].To
determine the appropriate dose of 5-FU necessary to confer
an eﬀective but recoverable level of cytotoxicity, mice were
treated with 50, 100 or 150mgkg−1 body weight of 5-FU. In
total, 100mgkg−1 body weight 5-FU induced a signiﬁcant
decrease (60–80% of the level of untreated controls) in
both bone marrow and spleen cell populations (data not
shown): therefore, in the following experiments, mice were
treated with 100mgkg−1 body weight of 5-FU, and then fed
with various Dioscorea tuber extracts or water only (vehicle
control).Wetreated micewith5-FUfor1dayand thenbegan
force-feeding them with DsCE-I or DsCE-II (10mgkg−1
body weight) from D. batatas for 5 consecutive days. After
six days, the average BMC count in untreated mouse hind
limbs was (4.22 ± 0.27) × 107 cells (100%) (Figure 3,b l a c k
bar). The average BMC count for cohort mice treated with
5-FU alone or 5-FU and DsCE-II of D. batatas was 1.17 ±
0.25 × 107 (27.7% to controls) and 2.46 ± 0.68 × 107 (58.3%
to controls), respectively. In other words, treatment with
DsCE-II approximately doubled the number of BMCs in 5-
FU-treated mice, recovering BMCs to half the number in
healthy mice. DsCE-I, however, conferred no eﬀect on BMC
regeneration. A similar DsCE-II protective eﬀect was also
observed for the regeneration of splenocyte cell populations
f r o mt h es a m es e to f5 - F U - t r e a t e dm i c e( Figure 3). Here, the
splenocyte cell numbers were 7.25 ± 0.41 × 107 (untreated,
no 5-FU and DsCE-II, 100%), 3.13 ± 0.21 × 107 (5-FU
treatment only, 43.2%), 3.52 ± 0.58 × 107 (5-FU treatment
plusDsCE-I,48.6%),and 4.98 ± 0.37 × 107 (5-FUtreatment
plus DsCE-II, 68.7%). An approximate 1.6-fold increase in
splenocyte population was found in the 5-FU-treated mice
given DsCE-II D. batatas,a sc o m p a r e dw i t h5 - F U - t r e a t e d
mice given water only (P<. 05) (Figure 3).
3.5. DsCE-II Treatment Restores Speciﬁc BMC Population in
5-FU-Treated Mice. To further evaluate the eﬀect of DsCE-
II on BMCs in vivo,w ea n a l y z e dt h ee ﬀect of DsCE-II on
the nucleated cell populations [21] in bone marrow tissue
of 5-FU-treated mice. Approximately 79% of the nucleated
cell populations were recovered in the 5-FU-treated and
DsCE-II-fed mice as compared with the untreated control
mice (100%) (data not shown). This represented ∼1.83-
fold increase in nucleated BMC count over the ∼43%
level obtained from the 5-FU and water-treated mice. In
comparison, feeding with extracts of an unrelated control
plant, (cucumber extract) conferred a marginal (∼51%)
recovery eﬀect on BMCs in test mice, which shows that the
eﬀectoftheDsCE-IIfractionwasspeciﬁctoplanttissue.This
result is also consistent with that shown in Figure 3.Evidence-Based Complementary and Alternative Medicine 5
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Figure 2: Eﬀect of ethanol-partitioned DsCE fractions of Dioscorea tuber extract on the proliferation of murine splenocytes, alone or in
combination with IL-2. (a) Splenocytes isolated from BALB/c mice were incubated with varying amounts (0–1000μgmL −1)o fD s C E - I ,- I I
or -III. Bars with diﬀerent alphabets represent signiﬁcant diﬀerences between treatments. (b) Splenocytes were incubated with increasing
amounts (0–500μgmL −1)o fD s C E - I Io fD. batatas Decne, in combination with 2ngmL−1 IL-2 in culture medium. The cpm value for
splenocytes treated with 2ngmL−1 IL-2 alone was determined at 1,864 ± 272. Open circles denote the growth activity of splenocytes treated
with DsCE-II; inverted open triangles show the experimentally observed stimulatory activity when DsCE-II and IL-2 were added together
to test cells; ﬁlled squares indicate the theoretical total activity determined by adding the individually obtained activities of DsCE-II and
IL-2 as a sum. This result indicates that DsCE-II and IL-2 have a synergistic eﬀect rather than an additive eﬀect. CPM values that diﬀered
signiﬁcantly from theoretical sum are marked. (c) The speciﬁc DsCE-II fractions extracted from the tuber of four diﬀerent species/cultivars
of Dioscorea spp. plants were tested alone or in combination with IL-2 for their abilities to stimulate splenocyte cell proliferation in culture.
After treatment for 48 h, test cells were then labeled with 3H-thymidine and harvested for assay as described in the ‘Methods’ section. The
data represent the mean ± SD of triplicate cell culture samples. Two other independent experiments were repeated and showed similar
results. Signiﬁcantdiﬀerence (∗∗∗P<. 001) between the group of DsCE-II with IL-2 coincubation and theoretic sum. ∗∗P<. 01.6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Fractionated tissue extracts of Dioscorea tuber eﬀectively
help to regenerate or recover test cells of bone marrow and spleen
tissues of 5-FU-treated BALB/c mice. Mice were pre-treated with
5-FU at 100mgkg−1 body weight; 24h later, test mice (three mice
per group) were force-fed for ﬁve consecutive days with 0 or
10mgkg−1 body weight of D. batatas Decne tuber extracts (DsCE-
I or DsCE-II). Experimental data are expressed as mean ± SD.
Filled squares indicate BMCs; open squares depict splenocytes.
Signiﬁcant diﬀerence (∗P<. 05) when compared with 5-FU
treatment control. An independent experiment was repeated and
similar results obtained.
3.6. DsCE-II Preferentially Stimulates Regeneration of CFU-
GM Cells in Bone Marrow. Nucleated BMCs from control
mice (without 5-FU), as well as nucleated BMCs from mice
pretreated with 5-FU and then force-fed water, cucumber
extract as negative controls, or DsCE-I or -II extracts were
subsequently cultured and quantitatively assayed for growth
of speciﬁc colony-forming units (CFU) of progenitor cells:
CFU-GEMM, CFU-GM and BFU-E. The number of CFU
grown from untreated mice in methylcellulose gel for the
three test cell types was consistent with those of previous
studies (Table 1)[ 19, 20]. The CFU numbers for CFU-GM,
BFU-E and CFU-GEMM cells in 5-FU-treated mice were
substantially reduced, to 27.6, 10.9 and 8.2%, respectively,
of numbers in control mice (Table 1) .O ft h em i c ef o r c e - f e d
with DsCE-II, populations of CFU-GM recovered to 67.3%
(P = .014): CFU-GEMM and BFU-E cell lineages recovered
substantially less, to 21.4% (P = .395) and 11.9% (P = .99),
respectively (Table 1). DsCE-II treatment produced ∼2.4-
fold (27.6–67.3%) and 2-fold (10.9–21.4%) recovery of GM
andBFU-Ecells,respectively, incomparison tothesame cells
in the mice treated with 5-FU and water. Slight reduction or
little change (8.2–11.9% = 3.7% of total CFU) was detected
for GEMM cells in DsCE-II treated mice (Table 1). We
observed much less eﬀect on the recovery of the three cell
types in the bone marrow tissues of 5-FU plus DsCE-I-
t r e a t e dm i c ei nc o m p a r i s o nw i t h5 - F Up l u sD s C E - I I - t r e a t e d
Table 1: Stimulatory eﬀect of DsCE-II on regeneration of myeloid
progenitor CFU-GM cells in bone marrow of 5-FU-treated mice.
Treatment CFU number × 10−2 (percentage of control)
GM (%) BFU-E (%) GEMM (%)
–5-FU
control 635.2 ± 42.1 (100)a 24.8 ± 6.3 (100) 29.2 ± 4.6 (100)
+5-FU
H2O 175.5 ± 17.1 (27.6) 2.7 ± 0.3 (10.9) 2.4 ± 0.4 (8.2)
Veg 205.7 ± 17.8 (32.4)∗ 3.1 ± 0.7 (12.5) 2.2 ± 0.4 (7.5)
DsCE-I 263.3 ± 18.7 (41.5) 2.4 ± 0.8 (9.7) 3.4 ± 1.0 (11.6)
DsCE-II 427.4 ± 49.2 (67.3)∗∗ 5.3 ± 0.9 (21.4) 3.5 ± 0.5 (11.9)
G-CSF 501.6 ± 15.7 (78.9)∗∗ 1.4 ± 0.5 (5.6) 7.3 ± 1.4 (25.0)
Mice were treated with 100mgkg−1 body weight 5-FU, after 24h mice
were force-fed with water, Dioscorea extracts (DsCE-I and II of D. batatas,
10mgkg−1 body weight), and vegetable (cucumber juice, 10mgkg−1 body
weight), or injected subcutaneously with G-CSF (5μgkg −1 body weight)
for ﬁve consecutivedays. BMCs were harvested and subjected to colony
assay as described in the ‘Methods’ section. Bone marrow of one hind
limb (femur and tibia) was assessed for CFU number. Data are expressed
as mean ± SD for a group of three mice. This experiment was performed
three times giving analogous results. Results are presented with data pooled
from two independent experiments. BFU-E: burst forming unit-erythroid;
CFU:colony-forming unit,GEMM: granulocyte, erythrocyte, monocyte and
megakaryocyte; GM: granulocyte and macrophage.
aPercentage of colony number over normal (no 5-FU) controls.
Signiﬁcant diﬀerence when compared with 5-FU treatment control ∗P<
.05; ∗∗P<. 01.
mice (Table 1). This trend of results was consistent in two
other independently repeated experiments.
We then tested the cytokine G-CSF, a recombinant
protein drug for assisting the recovery of leukocytes in bone
marrow chemotherapy patients as a ‘positive’ control of
the in vivo study. Subcutaneous administration of 5μgkg −1
recombinant murine G-CSF (rmG-CSF) eﬀectively recov-
ered test cells in 5-FU-treated mice to 78.9% of control
levels (no 5-FU) (Table 1). It had a modest eﬀect on GEMM
cells (25%) and little eﬀect (5.6%) on BFU-E cells. The
degree of recovery of CFU-GM cells in 5-FU and DsCE-
II-treated mice (67.3%), and 5-FU and G-CSF-treated mice
(78.9%) was quite similar, 2.44- and 2.86-fold, respectively,
higher than that of the mice given 5-FU plus water (27.6%).
Mice given 5-FU cucumber as a control, showed little or
no regeneration of CFU-GM, BFU-E or GEMM cells. The
data in Table 1 were obtained from an average of results
from two independent experiments. Furthermore, two other
experiments were carried out, and the eﬀect of DsCE-II
and G-CSF on the three progenitor cell lineages was similar.
These results suggest that DSCE-II is highly speciﬁc in its
action on diﬀerent bone marrow progenitor cell types.
Since hematopoietic progenitor cells can also be translo-
cated from the spleen into bone marrow tissue [25], we
surgically removed the spleens of test mice, and then
subjected the mice to the tests in Table 1.W eo b s e r v e d
8.2 ± 0.4, 27.4 ± 3.5 and 100 ± 9.2% of CFU-GM cells in
bone marrow tissues of mice without spleens treated with
5-FU and water or DsCE-II, or 5-FU alone, respectivelyEvidence-Based Complementary and Alternative Medicine 7
(complete set of data not shown). Thus, we observed a 3-
fold increase in CFU-GM cell recovery in mice given DsCE-
II as compared with those given water even in animals
with spleens removed, although the capacity for CFU-GM
recovery was considerably lower than in mice with intact,
healthy spleens (Table 1).
This result supports the ﬁnding that recovery of speciﬁc
BMC populations can be directly aﬀected by oral feeding
with DsCE-II.
3.7. Fractionation and Characterization DsCE-II Components.
The bioactive DsCE-II from D. batatas tuber extract was fur-
ther analyzed for its phytocompound components by anion
exchange column chromatography. By ﬁltering through a
Q Sepharose Fast Flow ion exchange column (Pharmacia),
seven subfractions (fractions #1–7, Figure 4(a))s h o w i n g
major absorbance peaks at 280 and 490 nm for polypeptides
and saccharides, respectively, were collected and subjected
to bioactivity testing using mouse splenocyte proliferation
enhancement assay. Fraction #4 conferred a level of speciﬁc
activity ∼3-fold higher than that of the unfractionated
DsCE-II,∼2-foldhigheractivitythanthatoffractions #1and
#2, and an 8- to 50-fold higher activity than that of fractions
#3, #5, #6 and #7 (Figure 4(b)). Fraction #4 contained
both polysaccharides and polypeptide components, and
SDS-PAGE analysis revealed that it contained a dominant
protein band, representing probably the major tuber storage
protein of Dioscorea, dioscorin, as conﬁrmed by N-terminal
protein sequencing. Bioactivity analysis further showed that
the increase in splenocyte proliferation by fraction #4 was
unlikely to be caused by protein substances that might
exist in the fraction, because exhaustive trypsinization of
fraction #4 did not signiﬁcantly (≤12%) reduce the resulting
bioactivity in the splenocyte proliferation assay (data not
shown). Additional experiments revealed that the ability of
DsCE-II to stimulate splenocyte proliferation was totally
inhibited by lipid A inhibitor (polymyxin B; P-1004, Sigma,
M O ,U S A ) ,b u tt h i sa c t i v i t yh a dl i t t l eo rn oe ﬀect on the
synergy between IL-2 and DsCE-II (data not shown).
Since the isolated DsCE-II material dissolved in aqueous
solution was viscous and gluey, this characteristic strongly
inﬂuenced the chromatographic ﬂow and contributed to
the asymmetrical proﬁle detected in fractionation by size-
exclusion chromatography using a TSK HW-55F column
(Figure 5(a)). A great majority of the DsCE-II molecules
are polysaccharides with an apparent molecular mass of
>100kDa, as determined by RI detector and the phenol-
sulfuric acid method, with the use of several dextrans,
including blue dextran (2000kDa), 500, 70 and 10kDa
dextrans, as molecular mass standards. DsCE-II may also
contain a very low level of high molecular weight polypep-
tides because some absorbance at 280 nm was detected. In
parallel, we characterized the chemical content in DsCE-
I, as referencing information to that of DsCE-II, because
DsCE-I showed no detectable activity compared with DsCE-
II (Figure 2(a)). As shown in Figure 5(b), symmetrical peaks
exhibiting a relatively high absorbance in RI detector as
well as at UV280 in size exclusion column were obtained for
DsCE-I, a watery, not viscous extract. Based on the sugar
Table 2: GC-MS sugar linkage analysis of DsCE-I and -II polysac-
charides extracted from D. batatas.
Percentage of total
carbohydrate
Sugar residuea
Ara Rha Fuc Xyl Man Gal Glc
DsCE-I 1.1 0.7 0.2 0.8 11.4 14.7 71.1
DsCE-II 4.2 0.5 0.1 0.7 64.4 13.3 16.6
aSugar residues and compositions were analyzed as described in Section 2.
composition and linkage analysis by GC-MS, we further
demonstratedthatDsCE-IandDsCE-IIcanbereadilydistin-
guished by their diﬀerence in composition of β-1,4-linkage
glucose versus β-1,4-linkage mannose (Table 2). We thus
suggest that the major immunomodulatory constituent(s)in
DsCE-II is likelycontributedby thehigh contentofmannose
polymer (≥64%). Further analyses are needed for gaining
more insights into the speciﬁc biochemical identities in the
DsCE-II and the fraction #4 components of the D. batatas
tuber extracts.
4.Discussion
This study provides scientiﬁc evidence for the immunomod-
u l a t o r ya c t i v i t yo ft u b e rt i s s u e so fDioscorea spp. The
Dioscorea tuber is widely used as a functional food or phy-
todrug in several Eastern Asian cultures. It is usually served
either as a fresh vegetable or in the form of stewed tubers
in tonic soups. Tuber slices are also an essential component
in many TCM recipes. It is striking that in ancient Chinese
herbal medicinal literature such as Ben-Cao-Kong-Mu [13],
Chinese medical doctors often relate the signiﬁcant positive
homeostatic/immune-regulatory eﬀects of Dioscorea tuber
speciﬁcally to the species D. batatas Decne., but not other
Dioscorea species. Our present study supports this historical
claim. In addition, in this study we demonstrate that speciﬁc
ingredients in DsCE-II, a fractionated tuber extract of D.
batatas, not only stimulated immune cell proliferation, but
also aided the regeneration of bone marrow and spleen in 5-
FU-pretreated animals.
The ability of Dioscorea to modulate immune signal
transduction in the regulation of cytokine expression has
recently been studied. A speciﬁc glycoprotein isolated from
D. batatas has been shown to inhibit the expression of
IL-4 and IL-10 through modulation of GATA3, STAT6
and p44/42 or p38 MAPK in primary mouse lymphocytes
[26]. And diosgenin, a steroidal sapogenin of Dioscorea,
was found to enhance antigen-speciﬁc expression of IgG2a
and IFN-γ, which may mediate the up-regulation of Th1
diﬀerentiation [27]. These ex vivo studies demonstrate that
phytocompounds from Dioscorea can modulate speciﬁc
immune system activities via regulation of speciﬁc cytokine
and chemokine networks. Our present study showed that
co-treatment with DsCE-II and cytokine IL-2 can promote
splenocyte proliferation. The dose-response proﬁles for
DsCE-II, both alone and in combination with IL-2, imply
that components of DsCE-II may interact with each other
or, more interestingly, with IL-2, perhaps synergistically. The
potentialforsynergybetweendiﬀerentcomponentsinherbal8 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Fractionation and characterization of phytocompound
components of DsCE-II. (a) Anion exchange column chromatogra-
phy of DsCE-II. DsCE-II fraction of D. batatas Decne was separated
into seven fractions [1–7] by use of a Q Sepharose ion exchange
column and eluted with 0–0.75 M NaCl salt gradient in 5mM
phosphate buﬀer (pH 7.0). Absorbance at 280 nm was recorded
for polypeptides, and absorbance at 490 nm of each fraction was
determined by use of the phenol-sulfuric acid method for the
content of saccharides as described in Section 2.( b )B i o a c t i v i t y
assay of subfractionated components of DsCE-II. The bioactivity
of each subfraction at (250μgmL −1) was measured by the murine
splenocyte proliferation assay as described in Section 2.N e g a t i v e
control, Con A (positive control, 1μgmL −1), and the original un-
fractionatedDsCE-IIextract (250μgmL −1)were assayedinparallel.
Data represent the mean ± SD of triplicate cell culture samples. A
repeated experiment showed similar results. Signiﬁcant diﬀerences
(∗∗∗P<. 001) between fractionated samples and the original un-
fractionated DsCE-II.
medicine mixtures is a fundamental concept in TCM [28].
One recent study [29] demonstrated a plausible molecular
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Figure 5: TSK HW-55F gel ﬁltration and proﬁling analysis of
polysaccharides of DsCE-I (a) and -II (b) fractions from D. batatas.
basis for the synergistic anti-tumor eﬀectoftwo components
of a TCM formulation. It will be interesting to determine in
future studies whether DsCE-II functions synergistically or
merely additivelywith IL-2 orothercytokinesinsplenocytes.
Oral administration of a TCM herbal extract has been
shown to induce proliferation of erythroid progenitor cells
in mice with 5-FU-induced anemia [30]. In this study, we
found that mice which were fed with a Dioscorea extract
recovereddamagedbonemarrow progenitorcellpopulations
that had been depleted by large doses of 5-FU. The improved
recovery of these speciﬁc immune cells in 5-FU plus DsCE-
II-treated mice in comparison with mice treated with 5-
FU alone, was highly consistent across three independent
experiments (Figure 3). In order to evaluate the underlying
cellular mechanism(s), we analyzed in more detail the
response of diﬀerent hematopoietic progenitor cell types in
mousebonemarrowtoDsCE-IItreatment.Therecoveryrate
in 5-FU-treated mice for CFU-GM cells mediated by DsCE-
II (D. batatas) was similar to that mediated by granulocyte
colony-stimulating factor (G-CSF), implying a potentialEvidence-Based Complementary and Alternative Medicine 9
clinical application of DsCE-II. G-CSF is a well-recognized
cytokine that can reduce the incidence of febrile neutropenia
in chemotherapy and is used as a supportive therapeutic
agent for patients undergoing bone marrow transplantation
[31]. A recent report shows that G-CSF can shift the balance
to granulopoiesis during myeloid lineage speciﬁcation by
activating STAT3 and stimulating SHP2 (Src homology
region 2 domain-containing phosphatase 2) phosphoryla-
tion in marrow progenitor cells [32]. Therefore, it will be
important to evaluate in future studies whether any of the
components in DsCE-II directly activate STAT3 and SHP2
phosphorylation to enhance CFU-GM or indirectly enhance
the expression of G-CSF, or whether other mechanisms are
responsible for the regeneration of speciﬁc BMCs.
Figure 6 shows our working hypothesis for the action
modespeciﬁcityofDsCE-IIinregeneratingorpromotingthe
growth of BMCs. Chemotherapy patients are often further
treated with G-CSF to recover their immune systems. Our
present study suggests that Dioscorea spp. may provide a
much less costly, alternative approach. Since DsCE-II is
an ethanol-partitioned fraction of an easily prepared, cold-
water extraction of fresh D. batatas plant tuber, it could be
readily made available in tablet or fresh paste form as a food
supplement. The possibility of oral ingestion of Dioscorea
tuber extract is especially attractive, because many Asian
people have already routinely taken orally the uncooked
or cooked tuber of this plant as a health food, for many
cases over hundreds of years. To our best knowledge, no
toxic eﬀects from the oral ingestion of fresh Dioscorea tuber
have been reported. In our preliminary studies (data not
shown), we observed that the derived DSCE-II materials
were safe in test mice, in terms of normal animal physiology,
behavior and general toxicity parameters. However, for
routine medicinal use of DsCE-II, clinical and toxicological
studies are required in future studies.
In this study, the administration of DsCE-II phytocom-
pounds via the oral route meant the gastrointestinal (GI)
tract was the initial tissue target for in situ interaction,
with the eﬀects of treatment then observed at distant
sites (i.e., bone marrow and spleen). Furthermore, the
phytocompound(s) responsible for these bio-activities had
a high molecular weight (≥100kDa) and are most likely
polysaccharide in nature. Therefore, we postulate that there
are two likely routes by which DsCE-II molecules reach their
target tissues, either: (i) the high-molecular-weight DsCE-II
moleculesareprocessedintosmallermoleculesandabsorbed
into GI tract tissues and then into the blood stream or
alternatively (ii) DsCE-II molecules interact directly, in high
molecular weight form, with the GI tissue. In the ﬁrst case,
oligosaccharides or other low-molecular-weight molecules
that result from digestion could be taken up by intestinal
tissues and absorbed into the circulation conferring their
action(s) on cells in the blood or at distant target sites.
Lysosomal α-mannosidase, for example, partially digests
speciﬁc oligomannose moieties for antigen processing via
CD1e by T-cells [33]. In the second case, a direct interaction
between high-molecular-weight phytocompounds and GI
tract tissues would have to occur; however, the possible
mechanism(s) of such interaction is not obvious. Three
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Figure 6: Hypothetical diagram for the eﬀect of Dioscorea extract
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recent ﬁndings may oﬀer clues about such possibilities.
First, it was reported that intestinal wall tissue is not totally
“sealed” but instead contains intercellular paths that can
expose various cell types (including dendritic cells and
other immune-responsive cells) of the internal intestinal
tissue to the nutrient contents of the GI tract, including
macromolecules and even debris or pathogens [34, 35]. Fur-
thermore, a high mannose-containing polysaccharide, with
speciﬁc oligosaccharide sequence and structures that acts as
a speciﬁc ligand for both DC-SIGN and DC-SIGN-receptor
molecules in dendritic cells was identiﬁed. DC-SIGN and
DC-SIGN-receptor molecules are two very important func-
tional molecules of a key immune cell type that plays a
central role in antigen presentation and other immune cell
activities [36]. In addition, the mycobacterial antigens, the
hexamannosylated phosphatidyl-myoinositols were recently
reported to stimulate CD1b-restricted T-cells for antigen
processing by CD1e [33]. Based on these and other reports
ontheroleofspeciﬁcpolysaccharidesasimmunomodulators
[36–41], we postulate that high-molecular-weight polysac-
charides in DsCE-II act on speciﬁc target cell types in the GI
tract (dendriticcells, intestinal epithelial cells, and T-cells) to
mediate a cascade of immunoregulatory activities leading to
the recovery of damaged cell populations following 5-FU or
other chemical insults in the bone marrow, spleen or other
immune cell systems.
In conclusion, we suggest that the D. batatas extract
DsCE-II should be considered for further development as
a dietary supplement alongside chemotherapy for cancer
treatment, and the co-stimulatory eﬀect of DsCE-II in
combination with IL-2 may be useful in alternative cancer
immunotherapy strategies.10 Evidence-Based Complementary and Alternative Medicine
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